Alyeska Investment Group’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-103,465
Closed -$952K 563
2018
Q2
$952K Buy
103,465
+3,309
+3% +$30.8K 0.01% 403
2018
Q1
$800K Sell
100,156
-100,903
-50% -$2.2M 0.01% 401
2017
Q4
$5.59M Sell
201,059
-150,000
-43% -$3.98M 0.04% 255
2017
Q3
$9.48M Buy
351,059
+6,270
+2% +$164K 0.07% 246
2017
Q2
$10M Buy
344,789
+118,339
+52% +$3.6M 0.08% 240
2017
Q1
$7.72M Buy
+226,450
New +$7.31M 0.06% 270
2016
Q4
Sell
-19,299
Closed -$653K 588
2016
Q3
$653K Sell
19,299
-62,693
-76% -$2.02M 0.01% 425
2016
Q2
$2.4M Buy
+81,992
New +$2.26M 0.02% 357
2015
Q4
Sell
-78,098
Closed -$1.82M 507
2015
Q3
$1.82M Sell
78,098
-48,443
-38% -$1.18M 0.02% 337
2015
Q2
$2.22M Buy
126,541
+2,049
+2% +$31.6K 0.03% 339
2015
Q1
$1.91M Sell
124,492
-19,856
-14% -$334K 0.03% 378
2014
Q4
$2.61M Buy
+144,348
New +$2.41M 0.04% 318

Other funds holding DERM

Alyeska Investment Group's DERM Position: Q3 2018 in Review

Alyeska Investment Group sold out of Dermira, Inc. (DERM) in Q3 2018, closing a stake of 103,465 shares — an estimated $952K sold.

Alyeska Investment Group first reported a position in DERM in Q4 2014 and held it in 12 quarters. The position peaked at $10M in Q2 2017. 105 funds tracked by Wall St. Rank hold DERM as of Q3 2018.

  • Alyeska Investment Group reported no remaining Dermira, Inc. position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 103,465 Dermira, Inc. shares in Q3 2018, an estimated $952K.
  • Alyeska Investment Group first reported a position in Dermira, Inc. in Q4 2014 and held it in 12 quarters.
  • Alyeska Investment Group's Dermira, Inc. position peaked at $10M in Q2 2017.
  • 105 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.